Phase I
While Sutro’s technological platform opens multiple therapeutic doors, the company’s singular focus on homogeneous molecules is a key part of its competitive strategy.
The new year began with a fairly low level of clinical trial news. Here’s a look.
BioSpace is proud to present its NextGen Bio “Class of 2021,” a list of up-and-coming life science startups in North America that recently launched.
2021 is off to a hopeful start for some companies, executives and scientists, while others are forced to fold programs and recalibrate.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 5, 2021.
It’s not particularly surprising that there wasn’t a lot of clinical trial news between Christmas and New Year’s, although there was some. Here’s a look.
Even with the holidays among us, there were a number of clinical trial announcements. Here’s a look.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 29, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 22, 2020.
AB Science SA reported promising data from its Phase IIb/III trial of masitinib in patients with confirmed mild to moderate Alzheimer’s disease.
PRESS RELEASES